CUE - Cue Biopharma, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Cash flows from operating activities
Net income
-38,250
-36,699
-38,980
-23,234
-7,658
Depreciation & amortisation
5,221
5,166
760.011
419.568
202.085
Stock-based compensation
7,928
6,521
7,174
2,775
889.556
Change in working capital
-3,949
-1,489
4,211
2,909
532.321
Accounts receivable
-604.898
-754.898
-
-
-
Accounts payable
-1,294
-1,153
376.147
-
-
Other working capital
-33,293
-30,843
-28,265
-13,396
-6,484
Other non-cash items
-
-4,278
345.101
4,928
65.91
Net cash provided by operating activities
-33,266
-30,797
-26,411
-12,192
-5,968
Cash flows from investing activities
Investments in property, plant and equipment
-
-46.353
-1,854
-1,205
-515.979
Purchases of investments
-25,084
-15,134
-39,500
-
-
Sales/maturities of investments
9,000
18,500
21,000
-
-
Other investing activities
-
-
-
-0.035
-0.033
Net cash used for investing activities
-15,984
3,447
-20,354
-1,205
-516.012
Cash flows from financing activities
Common stock issued
-
48,999
4,169
66,155
16,415
Common stock repurchased
-
-
0
-4,160
-1,410
Net cash used provided by (used for) financing activities
50,569
50,790
4,182
62,004
15,005
Net change in cash
1,319
23,440
-42,583
48,608
8,521
Cash at beginning of period
22,113
21,000
63,584
14,926
6,405
Cash at end of period
23,432
44,440
21,000
63,534
14,926
Free cash flow
Operating cash flow
-33,266
-30,797
-26,411
-12,192
-5,968
Capital expenditure
-
-46.353
-1,854
-1,205
-515.979
Free cash flow
-33,293
-30,843
-28,265
-13,396
-6,484